Chile Pharmaceuticals & Healthcare Report Q1 2015 - New Study Released
New Healthcare market report from Business Monitor International: "Chile Pharmaceuticals & Healthcare Report Q1 2015"
[USPRwire, Fri Jan 23 2015] Well into our extended forecast period, market conditions in Chile remain very attractive for multinational drugmakers. Although cost containment and measures to promote the uptake of generics are ongoing, the pace of reform is slow and entrants will continue to enjoy a relatively flexible operating environment. Notably, the private sector, which constitutes a disproportionate share of total spending, is markedly less price sensitive than public consumers and will continue to exhibit strong bias towards patented treatments; maintaining strong demand for pharmaceuticals.
* Pharmaceuticals: From CLP1,792bn (USD2.98bn) to CLP1,984bn (USD3.33bn) in 2014; +8.7% in local currency terms and -6.2% in US dollar terms. Up from Q414.
* Healthcare: From CLP10,237bn (USD16.84bn) to CLP11,167bn (USD18.37bn) in 2014; +9.1% in local currency terms. Unchanged from Q414.
Risk/Reward Index
With an RRI score of 53.9 out of 100 in Q115, Chile ranks 8 th of the 18 markets covered in the Americas matrix, losing its 6 th place to Argentina. This figure is down from a score of 56.3 in Q414.
Key Trends a nd Developments
* In October 2014, as reported by Reuters, Finance Minister Alberto Arenas announced that Chile's 2015 stimulus programme (authorising the government to issue up to USD8.0bn in local and foreign debt), which aims to boost investment in education and healthcare in order to counteract economic slowdown, may be scaled down from 2016 if growth hits targets above 4%.
* In July 2014, Chilean authorities put a policy in place, altering decree 466/84 that applies to pharmacies, drug and pharmaceutical stores. It implements a series of measures to begin the reduction of excessive drug use and a move towards a more transparent pharmaceutical market.
BMI Economic View: The Chilean economy will expand at a sluggish pace in the coming quarters, as weaker growth in China and deteriorating business confidence weigh on fixed investment....
The Chile Pharmaceuticals & Healthcare Report features Business Monitor International (BMI)'s forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.
BMI's Chile Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Chile pharmaceutical and healthcare industry.
Key Benefits
* Benchmark BMI's pharmaceutical and healthcare market forecasts for Chile, to test other views - a key input for successful budgeting and strategic business planning in the Chilean pharmaceutical and healthcare market.
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
You may also be interested in these related reports:
